Mirati Therapeutics OverviewMirati Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MRTX.
Quarterly EBIT
-$173.17M
↑ 7.12% YoY
As of Sep 30, 2023
Annual EBIT (TTM)
-$767.06M
↓ 2.97% YoY
Trailing 12 months ending Sep 30, 2023
Mirati Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for MRTX.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023